5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Zim Laboratories Ltd.

•
zimlab.inBSE: 541400NSE: ZIMLAB
Market Cap₹ 746 Cr.
Current Price
High / Low₹ 144 / 59
Stock P/E201.7
Book Value₹ 54
Price to Book1.09
Dividend Yield0.00 %
ROCE5.5 %
ROE2.1 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has consistently been profitable over the last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.03x)
  • Company maintains a comfortable, low leverage position

CONS

  • A large part of profit comes from other income (138.6% of PBT)
  • Recent results are weak - TTM profit is down 38.6% versus prior year
  • Company has a low return on equity of 5.0% over last 3 years
  • Company has a low return on capital employed of 8.0%
  • Promoter holding has decreased over last 2 years: -2.9pp
  • Interest coverage is weak at 1.6x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.ZIMLAB138.95201.73745.580.00-4.02-114.2494.1831.245.472.60
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
678696118829296109728910910594
6376851027483859468839698101
Operating Profit591216810121546137-7
OPM %7.16%10.87%11.97%13.27%9.81%10.34%12.00%13.42%5.94%6.48%11.79%6.83%-6.97%
1112112212261
Interest2122333333334
Depreciation4444555555555
Profit before Tax057111368-2-065-6
Tax %-21.05%23.71%31.81%26.45%27.64%19.59%29.82%39.70%23.05%-23.53%27.27%24.29%27.92%
Net Profit00001245-2-044-4
0.050.850.981.660.180.490.821.01-0.38-0.090.900.76-0.75

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
235273335278307333399367379374397
204238293255268292347326335344378
Operating Profit3135422340415241443019
OPM %13.40%12.75%12.53%8.14%12.94%12.29%13.04%11.25%11.54%8.02%4.83%
6925-346561111
Interest109111311867111314
Depreciation910111416161716202020
Profit before Tax1725220102135241885
Tax %-6.21%23.36%30.49%-4705.54%28.48%30.85%30.89%27.05%32.45%28.91%27.06%
Net Profit191915371524171264
EPS22.9311.799.452.034.502.995.013.542.501.09—
Dividend Payout %2.16%2.11%5.25%0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
3%
5 Years:
4%
3 Years:
-2%

COMPOUNDED PROFIT GROWTH

10 Years:
1%
5 Years:
-4%
3 Years:
-38%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
5%
1 Year:
86%

RETURN ON EQUITY

10 Years:
9%
5 Years:
7%
3 Years:
5%
Last Year:
2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2022

Dec 22

2:1

Quarterly Results & Bonus issue

2018

Oct 4

1:1

Bonus issue

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital881616161649494954
110128134137145159152190202240
818377908152609495105
Trade Payables45667266658158627073
692810153423525869
Total Liabilities250295328320322343342447473540
8994106116107106109161164162
Capital Work in Progress35855518244459
35525556547554818694
0000000100107109
Cash & Bank643485810243
117141156139148152154716973
Total Assets250295328320322343342447473540

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
35413627335045164150
Cash from Investing-7-26-21-19-6-15-36-73-40-56
Cash from Financing-25-10-15-2-26-33160-928
-01-10-0233-821

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
33.2633.2633.2633.2633.2633.2633.2630.3530.36
0.000.000.210.010.030.000.020.000.03
0.000.000.160.160.160.160.120.001.34
Government0.000.000.000.000.000.000.000.000.00
66.7366.7366.3766.5766.5466.5866.6069.6568.28

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-12 - Zim Laboratories Limited has informed the Exchange about Transcript

2026-08-12
Shareholders meeting

2026-08-12 - Zim Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

2026-08-08
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-08 - Zim Laboratories Limited has informed the Exchange about Link of Recording

2026-08-07
Copy of Newspaper Publication

2026-08-07 - Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-06
General Updates

2026-08-06 - Zim Laboratories Limited has informed the Exchange about Earnings Presentation - Q1 FY27

2026-08-06
Outcome of Board Meeting

2026-08-06 - Zim Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-04 - Zim Laboratories Limited has informed the Exchange about Schedule of meet

2026-07-30
Copy of Newspaper Publication

2026-07-30 - Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

2026-07-13
Allotment of Securities

2026-07-13 - Zim Laboratories Limited has informed the Exchange regarding allotment of 109451 securities pursuant to ESOP/ESPS at its meeting held on July 13, 2026

News

Recent coverage and analyst commentary for ZIMLAB

Loading news…

🤖

AI Stock Analyst

Zim Laboratories Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login